Fresenius pushes further into generics
Monday, May 1, 2017 - 00:11
in Mathematics & Economics
German firm to acquire U.S. generics maker Akorn and Merck KGaA’s biosimilars business
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via